Zappacosta Bruno, Romano Lucio, Guerriero Massimiliano, Graziano Mirella, Vitrani Antonia, De Ninno Maria, Carbone Arnaldo
Department of Laboratory Medicine and Pathology, Centro di Ricerche e Formazione ad Alta Tecnologia nelle Scienze Biomediche "Giovanni Paolo II", Università Cattolica del S. Cuore, Campobasso, Italy.
New Microbiol. 2009 Oct;32(4):351-8.
We evaluated the prevalence of human papillomavirus (HPV) infection and correlated the molecular test results with the cytological examination data (PAP test) in 364 women living in central-southern Italy (Molise region), by means of polymerase chain reaction HPV DNA genotyping and of cervical cytology. One hundred and twenty-eight women resulted HPV positive (35.2%), HPV16 being the most frequent genotype. HPV positive women were significantly younger than negative patients (35.9 +/- 8.4 years and 38.2 +/- 9.1, respectively; p = 0.018); women with multiple infections were also significantly younger than those with single infection (31.7 +/- 6.9 and 37.6 +/- 8.3, respectively; p = 0.0002). Moreover, high risk HPV positive patients were significantly younger than low risk HPV positive women (35.1 +/- 7.7 and 40.5 +/- 10.5, respectively; p = 0.008). In the HPV positive group, 14 patients (10.9%) did not show any significant cytological alteration. Conversely, 7 out of 236 HPV negative women (3.0%) showed high grade squamous intraepithelial lesions (HSIL). Furthermore, HPV 16 or 18 were present in more than 70% of women positive for HSIL at cytology. Our data suggest the potential effectiveness of combined cytology and molecular test for further study of clinical cases with apparently laboratory conflicting results.
我们通过聚合酶链反应HPV DNA基因分型和宫颈细胞学检查,评估了意大利中南部(莫利塞地区)364名女性的人乳头瘤病毒(HPV)感染率,并将分子检测结果与细胞学检查数据(巴氏试验)进行了关联分析。128名女性HPV检测呈阳性(35.2%),HPV16是最常见的基因型。HPV阳性女性明显比阴性患者年轻(分别为35.9±8.4岁和38.2±9.1岁;p = 0.018);多重感染的女性也明显比单一感染的女性年轻(分别为31.7±6.9岁和37.6±8.3岁;p = 0.0002)。此外,高危HPV阳性患者明显比低危HPV阳性女性年轻(分别为35.1±7.7岁和40.5±10.5岁;p = 0.008)。在HPV阳性组中,14名患者(10.9%)没有显示出任何明显的细胞学改变。相反,236名HPV阴性女性中有7名(3.0%)显示出高级别鳞状上皮内病变(HSIL)。此外,细胞学检查HSIL阳性的女性中,超过70%的人存在HPV 16或18感染。我们的数据表明,对于实验室结果明显相互矛盾的临床病例,联合细胞学和分子检测可能具有潜在的有效性。